{"name": "Apthera",
 "permalink": "apthera",
 "crunchbase_url": "http://www.crunchbase.com/company/apthera",
 "homepage_url": "http://www.apthera.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "mwschwartz@apthera.com",
 "phone_number": "(925) 915-1343",
 "description": "",
 "created_at": "Fri Apr 01 03:21:19 UTC 2011",
 "updated_at": "Fri Apr 01 03:21:18 UTC 2011",
 "overview": "\u003Cp\u003EApthera, Inc., a biotechnology company, develops and produces peptide-based cancer immunotherapy solutions. It offers products for the treatment of breast and prostate cancers. The company was founded in 2005 and is based in Scottsdale, Arizona.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[130,
       49],
      "assets/images/resized/0012/8719/128719v1-max-150x150.jpg"],
     [[130,
       49],
      "assets/images/resized/0012/8719/128719v1-max-250x250.jpg"],
     [[130,
       49],
      "assets/images/resized/0012/8719/128719v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Mark",
      "last_name": "W. Schwartz",
      "permalink": "mark-w-schwartz",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Robert",
      "last_name": "E. Kennedy",
      "permalink": "robert-e-kennedy",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 7000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.masshightech.com/stories/2011/03/28/daily42-RXi-buying-Apthera-for-7M-getting-late-stage-drug.html",
   "source_description": "RXi buying Apthera for $7M, getting late-stage drug",
   "acquired_year": 2011,
   "acquired_month": 3,
   "acquired_day": 31,
   "acquiring_company":
    {"name": "RXi Pharmaceuticals",
     "permalink": "rxi-pharmaceuticals",
     "image":
      {"available_sizes":
        [[[150,
           35],
          "assets/images/resized/0012/4572/124572v1-max-150x150.png"],
         [[250,
           58],
          "assets/images/resized/0012/4572/124572v1-max-250x250.png"],
         [[255,
           60],
          "assets/images/resized/0012/4572/124572v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8418 E. Shea Blvd",
    "address2": "Suite 100",
    "zip_code": "85260",
    "city": "Scottsdale",
    "state_code": "AZ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}